Malinowska Katarzyna, Zielińska-Bliżniewska Hanna, Majsterek Ireneusz, Olszewski Jurek
Zakład Chemii Biochemii Klinicznej, Katedry Nauk Podstawowych i Przedklinicznych UM w Łodzi, Kierownik: dr hab. n. biol. I. Majsterek, Poland.
Otolaryngol Pol. 2013 Sep-Oct;67(5):228-32. doi: 10.1016/j.otpol.2013.02.005. Epub 2013 Feb 13.
The aim of this study was synthesized properties 1,2,4-triazole complex ion Cu (II) to determine their potential antioxidant properties, further indication of activity of antioxidant enzymes: catalase (CAT), glutathione peroxidase (GPX) and superoxide dismutase (Cu-Zn SOD) in patients with nasal polyps and the control group.
The study was conducted in a group of 30 patients with nasal polyps aged 48±13.50 (test 1 - group with a compound, test 2 - no relation), and 30 in the control group aged 48±17.90 (control 3 - group with a compound, control 4 - no relation). Blood samples were collected from the antecubital vein into tubes with anticoagulant (heparin sodium). The activity of catalase, superoxide dismutase and glutathione peroxidase were determined in erythrocytes of patients with nasal polyps and the control group (those without inflammatory conditions.
We found that patients with nasal polyps show a decrease in the activity of antioxidant enzymes compared to control: CAT (control 3 - 13.78±6.71 BU/gHb; test 1 - 8.52±7.96 BU/gHb), SOD (control 3 - 1377,614.93±93.44 U/gHb/100ml; test 1 - 867,270.59±49 U/gHb/100ml) and GPX (control 3 - 101.62±8.23 U/gHb; test 1 - 72.97±14.34 U/gHb). Simultaneously, we observed that increasing the activity of antioxidant enzymes compared in the groups control 4 to test 2 (in groups which do not given coordination compound Cu (II): CAT (control 4 - 13.38±7.60 BU/gHb; test 2 - 10.12±3.62 BU/gHb) SOD (control 4 - 1138.88±490.10 U/gHb/100ml; test 2 - 1283.85±439.87 U/gHb/100ml) and GPX (control 4 - 65.18±20.94 U/gHb; test 2 - 90.27±19.42 U/gHb).
The study shows that the complex deacon-tetra (N1,3-triazole,кN2) copper (II) affects the activity of antioxidant enzymes CAT, SOD and GPX.
本研究旨在合成1,2,4 - 三唑络合铜离子(II)以确定其潜在的抗氧化性能,进一步表明鼻息肉患者和对照组中抗氧化酶:过氧化氢酶(CAT)、谷胱甘肽过氧化物酶(GPX)和超氧化物歧化酶(铜 - 锌超氧化物歧化酶)的活性。
该研究在一组30例年龄为48±13.50岁的鼻息肉患者中进行(试验1 - 有化合物组,试验2 - 无关联组),以及30例年龄为48±17.90岁的对照组患者中进行(对照3 - 有化合物组,对照4 - 无关联组)。从前臂静脉采集血液样本至含有抗凝剂(肝素钠)的试管中。测定鼻息肉患者和对照组(无炎症情况者)红细胞中过氧化氢酶、超氧化物歧化酶和谷胱甘肽过氧化物酶的活性。
我们发现,与对照组相比,鼻息肉患者的抗氧化酶活性降低:CAT(对照3 - 13.78±6.71 BU/gHb;试验1 - 8.52±7.96 BU/gHb),SOD(对照3 - 1377.614.93±93.44 U/gHb/100ml;试验1 - 867.270.59±49 U/gHb/100ml)和GPX(对照3 - 101.62±8.23 U/gHb;试验1 - 72.97±14.34 U/gHb)。同时,我们观察到在未给予铜(II)配位化合物的组中,对照4组与试验2组相比抗氧化酶活性增加:CAT(对照4 - 13.38±7.60 BU/gHb;试验2 - 10.12±3.62 BU/gHb),SOD(对照4 - 1138.88±490.10 U/gHb/100ml;试验2 - 1283.85±439.87 U/gHb/100ml)和GPX(对照4 - 65.18±20.94 U/gHb;试验2 - 90.27±19.42 U/gHb)。
该研究表明,乙二胺四(N1,3 - 三唑,κN2)铜(II)络合物影响抗氧化酶CAT、SOD和GPX的活性。